• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Heart Pump Devices Market Share

    ID: MRFR/MED/4576-HCR
    100 Pages
    Kinjoll Dey
    October 2025

    Heart Pump Devices Market Research Report Information, By Product (Ventricular Assist Devices, Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi- Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pumps, And Total Artificial Heart), By Device Type (Implantable Heart Pump Devices, and Extracorpo...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Heart Pump Devices Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Share

    Heart Pump Devices Market Share Analysis

    In the Heart Pump Devices Market which is an essential market of the medical devices industry the companies that are selling their products are using various market share positioning strategies to become competitive and at the same time satisfying growing demands for new cardiac solutions. A common method is differentiating themselves in ways where they were either able to create unique features that their competitors could not or, possibly, using highly advanced technology in their heart pump devices. The development of this strategy certainly attracts the professionals who are looking for the unconventional and the radical solutions, but at the same time it can appeal to those patients who are ever more demanding in their choice of healthcare solutions.

    Additionally, producers of the apparatus for sales in the heart pump devices business as a rule evaluate cost leadership as a strategic approach. Through increasing efficiency of production, getting economies of scale and supply chain, organizations can offer their products for a competitive price without undermining on quality. This can be observed in markets where medical care-providing professionals and institutions have cost-effectiveness as a key factor.

    Collaboration and partnerships program is also among the strategies that promote the heart pumps. The healthcare organizations frequently cooperate with research centers, healthcare providers or other companies from industry to increase their awareness and get hold of limitlessly useful resources. Such joint endeavors may result into joint research efforts, clinical trials and a more in-depth knowledge of patient requirements. Perhaps, these all will influence on the manufacture of the heart pump systems that are more effective, customized and require less invasive treatment.

    Positional manipulation of markets also denotes prominence in the heart pump devices segmentation strategy. Companies are geographically focusing their cardiovascular disease intervention strategies by launching campaigns in areas with a higher prevalence of the condition. This helps them set-up shop in the right market segments and capture a more significant client base. Such a localized focus, for example, in marketing, distribution channels, and product offerings to cater for the needs and specific regulations in each region helps companies to have a more localized and the targeted approach

    Apart from that, the firms manufacturing the heart pumps are all the time putting a lot of effort and resources in the research and development aiming at staying on the edge of the technology improvement. Via continuous innovating and the introduction of new features, they are able to have the top notch standing among the industry personalities and doctors who look for brands that offer the latest and most effective solutions for their patients.

    In addition, customer-oriented approach should be one of the key success factors in occupying good market share in the doubly implanted heart pumps devices industry. By getting a grip of healthcare professionals' and patients' requirements and tastes companies are in a position to tweak their products and services as much as it is needed. This science-based strategy contains a customer proposition in which the feedback is gathered, market research is conducted, and user-industry friendly features are incorporated to make the experience a smooth ride for both professionals in medical field and their patients.

    Market Summary

    The Global Heart Pump Devices Market is projected to experience substantial growth from 0.74 USD Billion in 2024 to 6.31 USD Billion by 2035.

    Key Market Trends & Highlights

    Heart Pump Devices Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate (CAGR) of 20.2% from 2025 to 2034.
    • By 2035, the market valuation is anticipated to reach 5.6 USD Billion, reflecting a significant increase from the base year.
    • in 2024, the market is valued at 0.74 USD Billion, indicating a strong foundation for future expansion.
    • Growing adoption of heart pump devices due to increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.74 (USD Billion)
    2035 Market Size 6.31 (USD Billion)
    CAGR (2025-2035) 21.50%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Medtronic, Abbott Laboratories, Abiomed, Getinge, Syncardia Systems, Teleflex, Reliantheart, Terumo, Berlin Heart, Jarvik Heart, Cardiacassist, Fresenius Medical Care, Thoratec Corporation

    Market Trends

    The rising tendency of heart diseases is driving the market growth

    Market CAGR for heart pump devices is being driven by the rise in heart-related diseases and technological updates. The spread of cardiovascular disorders is rising, which is driving demand for heart pump devices worldwide. Thousands of people affected by cardiovascular diseases (CVDs), a major reason of morbidity and mortality worldwide, include many medical illnesses such as heart failure, coronary artery disease, and cardiomyopathy. As the world's population ages and sedentary lifestyles grow more common, the incidence of CVDs is predicted to rise quickly, driving demand for innovative therapies and technologies like heart pump devices.

    A deeper understanding of heart disease and advancements in medical technology have also led to earlier and more frequent diagnoses, which has raised the demand for heart pump devices.

    Additional factors influencing the growth of the heart pump device market include the rising availability of reimbursement for these devices and improvements in device design and manufacturing that have boosted safety and efficacy. The World Health Organization (WHO) reported that cardiovascular illnesses are the main reason of mortality worldwide, taking an estimated 17.9 million lives annually. Heart attacks & strokes account for four out of every five deaths from cardiovascular illnesses. As a result, the market for heart pump devices is always growing.

    Additionally, the worldwide aging population is a significant factor driving the market for heart pump devices. The market's businesses are working to improve the effectiveness and dependability of cardiac plant devices by creating fresh goods. Additionally, there is a great need for Heart Pump Devices due to the shortage of heart donors. The  Heart Pump Devices Market will have a positive growth trend as a result of all these factors. Thus, driving the Heart Pump Devices Market revenue.

    .webp

    The ongoing advancements in heart pump technologies are poised to enhance patient outcomes and expand treatment options for those with severe heart conditions.

    U.S. Food and Drug Administration (FDA)

    Heart Pump Devices Market Market Drivers

    Market Growth Projections

    The Global Heart Pump Devices Market Industry is projected to experience substantial growth over the coming years. With a market value of 0.74 USD Billion in 2024, it is anticipated to reach 5.6 USD Billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 20.2% from 2025 to 2035. This growth trajectory indicates a strong demand for heart pump devices, driven by factors such as technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditures. The market's expansion is indicative of the critical role these devices play in modern cardiovascular care.

    Rising Healthcare Expenditure

    Global healthcare expenditure is on the rise, which positively impacts the Global Heart Pump Devices Market Industry. Increased funding allows for the adoption of advanced medical technologies, including heart pump devices, as healthcare systems strive to improve patient care. With a projected compound annual growth rate (CAGR) of 20.2% from 2025 to 2035, the market is poised for substantial growth. This financial commitment from governments and private sectors facilitates research and development, leading to innovative solutions that address the growing burden of cardiovascular diseases.

    Increasing Geriatric Population

    The aging population worldwide is a significant factor contributing to the growth of the Global Heart Pump Devices Market Industry. As individuals age, the risk of developing cardiovascular diseases increases, leading to a higher demand for heart pump devices. By 2035, the market is anticipated to expand significantly, driven by the needs of this demographic. The geriatric population often requires specialized care, and heart pump devices provide essential support for managing chronic heart conditions. This demographic shift underscores the necessity for healthcare systems to adapt and invest in advanced heart pump technologies.

    Rising Prevalence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases globally is a primary driver of the Global Heart Pump Devices Market Industry. As heart-related ailments continue to escalate, the demand for effective treatment options, including heart pump devices, rises correspondingly. With projections indicating that the market will reach 0.74 USD Billion in 2024, healthcare providers are compelled to adopt advanced technologies to manage these conditions. This trend is likely to persist, as cardiovascular diseases remain a leading cause of morbidity and mortality worldwide, necessitating innovative solutions to improve patient outcomes.

    Growing Awareness and Education on Heart Health

    There is a notable increase in awareness and education regarding heart health, which drives the Global Heart Pump Devices Market Industry. Public health campaigns and educational initiatives are informing individuals about the risks associated with cardiovascular diseases and the available treatment options. As patients become more informed, they are more likely to seek medical intervention, including the use of heart pump devices. This heightened awareness is expected to contribute to the market's growth, as more individuals recognize the importance of early diagnosis and treatment in managing heart conditions.

    Technological Advancements in Heart Pump Devices

    Technological innovations play a crucial role in shaping the Global Heart Pump Devices Market Industry. The development of miniaturized, more efficient, and biocompatible devices enhances patient comfort and outcomes. For instance, advancements in ventricular assist devices (VADs) have significantly improved their functionality and reliability. As these technologies evolve, they are expected to attract more investment and research, potentially leading to a market valuation of 5.6 USD Billion by 2035. The continuous evolution of these devices indicates a promising future for patients requiring mechanical circulatory support.

    Market Segment Insights

    Heart Pump Devices Product Insights

    The Heart Pump Devices Market segmentation, based on product includes Ventricular assist devices, Left ventricular assist devices, Right ventricular assist devices, Bi- ventricular assist devices, Percutaneous ventricular assist devices, Transcutaneous ventricular assist devices, Intra-Aortic balloon pumps, Total artificial heart. During the projected period, it is anticipated that demand for left ventricular assist devices will increase quickly. The dependence on ventricular assist devices for the treatment of heart failure and technological improvements to boost the safety of these devices are credited with the growth.  

    Heart Pump Devices Device Type Insights

    The Heart Pump Devices Market segmentation, based on device type, includes Implantable heart pump devices, and Extracorporeal heart pump devices. During the projected period, the implantable heart pump devices sector is anticipated to develop at the greatest CAGR. The development of implantable heart devices through technology, which has increased their reliability and safety, is credited with the expansion of this market. Due to technical developments, these gadgets are now far more efficient. Patients who are not candidates for heart transplant surgery can use these devices over the long term as a means of survival.  

    Heart Pump Devices Therapy Insights

    The Heart Pump Devices Market segmentation, based on therapy, includes Bridge-to-candidacy (BTC), Bridge-to-transplant (BTC), Destination therapy (DT), and Others. Due to an increase in lung and heart transplants, the bridge-to-transplant (BTC) sector experienced the fastest growth rate in the market for heart pump devices. Nearly 70,000 adult lung transplants have been registered since the International Thoracic Organ Transplant (TTX) was founded, and each one has given a recipient with an end-stage lung disease the chance to regain quality of life and longevity, according to data on transplant procedures compiled by the International Society for Heart and Lung Transplantation (ISHLT).

    Heart Pump Devices End-User Insights

    The Heart Pump Devices Market segmentation, based on end-user, includes Hospitals & Clinics, Ambulatory surgical centers, Research institutes, and Others. The largest share belonged to the hospitals & clinics segment. This is explained by the increase in hospital patient visits brought on by the increased prevalence of cardiovascular disorders. The easy availability of payment for such treatments, which helps to lessen the financial strain on patients, is another factor contributing to the rise in the number of cardiac assist device implants. For instance, according to a survey, over 7.7 million people in the UK suffer from circulatory system illnesses.

    Figure 1 Heart Pump Devices Market, by End-User, 2022 & 2032 (USD Billion)

    Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

    Get more detailed insights about Heart Pump Devices Market Research Report – Forecast to 2034

    Regional Insights

    By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Heart Pump Devices Market area will dominate this market. Due to the rising percentage of people suffering from heart strokes and diseases, the region is one of the leading manufacturers and consumers in this industry.

    Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2  HEART PUMP DEVICES MARKET SHARE BY REGION 2022 (USD Billion)HEART PUMP DEVICES MARKET SHARE BY REGION

    Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

    Europe’s Heart Pump Devices Market accounts for the second-largest position in the market due to the increasing technological development across mechanical circulatory care. Further, the German Heart Pump Devices Market held the largest market share, and the UK Heart Pump Devices Market was the quickest-growing market in the European region

    The Asia Pacific Heart Pump Devices Market is anticipated to expand at the quickest CAGR. This is due to the rising awareness established via product developments and research centers programs. Moreover, China Heart Pump Devices Market held the fastest CAGR, and the India Heart Pump Devices Market was the quickest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Leading market players are investing largely in research and development to grow their product/service lines, which will aid the Heart Pump Devices Market, to grow even faster. Market leaders are also adopting a variety of strategies to expand their worldwide position, with important market developments including new product launches & developments, contractual agreements among companies with complementary service lines, mergers & acquisitions, higher investments, & collaboration with other organizations having complementary products and services. To grow in a competitive and rising market climate, the Heart Pump Devices industry needs to offer cost-efficient products.

    Producing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  Heart Pump Devices industry to benefit clients and increase the market sector. In recent years, the Heart Pump Devices industry has offered some of the most significant advantages to medicine. Major players in the Heart Pump Devices Market, including Medtronic, Abbott Laboratories, Abiomed, Getinge, Syncardia Systems, Teleflex, Reliantheart, Terumo, Berlin Heart, Jarvik Heart, Cardiacassist, Fresenius Medical Care, Thoratec Corporation, and others are attempting to increase market growth via investing in research and development operations.

    A wide variety of healthcare goods are discovered, developed, produced, and sold by Abbott Laboratories (Abbott), including branded generic medications, diagnostic tools and procedures, and infant, child, and adult nutritional supplements. The business also sells a range of medical devices, such as those for neuromodulation, electrophysiology, rhythm control, vascular and structural cardiac devices, and heart failure. The business also sells dietary supplements, minerals, and nutrition goods. It runs manufacturing sites all around the world and has research and development centers in the US, China, Colombia, India, Singapore, Spain, and the UK.

    The corporation sells its goods across Africa, the Middle East, Latin America, North America, and the Asia-Pacific region. In August 2023, According to recently released data from Abbott, the HeartMate 3TM heart pump improves patients' lives by at least five years and represents a definite life-saving alternative for those dealing with severe disease.

    For the treatment of severe heart failure, Jarvik Heart creates miniature heart assist devices. The Jarvik 2000 Ventricular Assist Device, a popular heart pump made by Jarvik Heart, has received CE Mark approval in Europe for both bridge-to-transplant and lifetime use. The PMDA in Japan has given the Jarvik 2000 permission to be used as a bridge to transplant. The Jarvik 2000 is a research device that offers patients lifetime support in the United States. There have been more than 1000 Jarvik 2000 implants performed ly.

    Patients in need of organ transplants as well as those who choose to utilize the Jarvik 2000 for the rest of their lives have had sustained and enhanced health thanks to it. In February 2019, At the National Research Centre for Cardiac Surgery in Astana, Kazakhstan, a ground-breaking medical innovation was made public. Top heart failure specialists from across the world revealed the successful implantation of a FIVAD (Fully Implanted Ventricular Assist Device) into a human at a news conference held at the Centre.

    Key Companies in the Heart Pump Devices Market market include

    Industry Developments

    December 2022 Abiomed declares The two first patients are enrolled in the Impella ECP Pivotal Trial, which has already received FDA approval for the type of Impella ECP that will be utilized. The operations were directed by Amir Kaki, MD, head of mechanical circulatory support at Ascension St. John Hospital in Detroit.

    January 2022 The world's most cutting-edge artificial heart, or Left Ventricular Assist Device (LVAD), is being developed, according to the School of Medical Research and Technology (SMRT), IIT-Kanpur.

    .webp

    Future Outlook

    Heart Pump Devices Market Future Outlook

    The Global Heart Pump Devices Market is projected to grow at a 21.50% CAGR from 2024 to 2034, driven by technological advancements, increasing cardiovascular diseases, and rising geriatric population.

    New opportunities lie in:

    • Develop innovative miniaturized heart pump devices for outpatient settings.
    • Leverage AI for predictive analytics in patient monitoring and device management.
    • Expand into emerging markets with tailored heart pump solutions.

    By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in cardiovascular treatment solutions.

    Market Segmentation

    Heart Pump Devices Regional Outlook

    North America
    • US
    • Canada

    Heart Pump Devices Product Outlook 

    • Ventricular assist devices
    • Left ventricular assist devices
    • Right ventricular assist devices
    • Bi- ventricular assist devices
    • Percutaneous ventricular assist devices
    • Transcutaneous ventricular assist devices
    • Intra-Aortic balloon pumps
    • Total artificial heart

    Heart Pump Devices Therapy Outlook 

    • Bridge-to-candidacy (BTC)
    • Bridge-to-transplant (BTC)
    • Destination therapy (DT)
    • Others

    Heart Pump Devices End-user Outlook 

    • Hospitals & Clinics
    • Ambulatory surgical centers
    • Research institutes
    • Others

    Heart Pump Devices, Device type Outlook 

    • Implantable heart pump devices
    • Extracorporeal heart pump devices

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024    0.74 (USD Billion)
    Market Size 2025    0.90 (USD Billion)
    Market Size 2035 6.31 (USD Billion)
    Compound Annual Growth Rate (CAGR) 21.50% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Device Type, Therapy, End-User, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Medtronic, Abbott Laboratories, Abiomed, Getinge, Syncardia Systems, Teleflex, Reliantheart
    Key Market Opportunities Growing technological updates across the medical industry
    Key Market Dynamics Increasing number of heart diseases and strokes among the population

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth of the Heart Pump Devices market?

    The Heart Pump Devices market is the expected increase in total market value of 6.31 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Heart Pump Devices market?

    Heart Pump Devices market size was valued at approximately 0.74 billion USD in 2024. This figure will reach 6.31 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Heart Pump Devices market?

    Heart Pump Devices market is expected to grow at a CAGR of 21.5% between 2025 and 2035.

    How much will the Heart Pump Devices market be worth by 2035?

    Heart Pump Devices market is expected to be worth of 6.31 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Heart Pump Devices market perform over the next 10 years?

    Over the next 10 years the Heart Pump Devices market is expected to shift from usd billion 0.74 to 6.31 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the Heart Pump Devices Market?

    North America had the largest share of the market

    1. Report Prologue
    2. Market Introduction
      1. 2.1
      2. Definition
      3. Scope Of The Study
        1. Research Objective
        2. Limitations
      4. 2.2.2
      5. Assumptions
    3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    4. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Technology Trends &
      7. Assessment
      8. Disease Prevalence And Diagnosis Analysis, By Country
      9. 5.
      10. Market Factor Analysis
      11. Porter’s Five Forces Analysis
        1. Bargaining
        2. Bargaining Power Of Buyers
        3. Threat Of New
        4. Threat Of Substitutes
        5. Intensity Of Rivalry
      12. Power Of Suppliers
      13. Entrants
      14. 5.2
      15. Value Chain Analysis
      16. Investment Feasibility Analysis
      17. Pricing Analysis
    5. Global Heart Pump Devices Market, By Product
      1. Introduction
      2. 6.2
      3. Ventricular Assist Devices
      4. • Market Estimates & Forecast, 2023-2032
    6. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. 6.2.1
      2. Left Ventricular Assist Devices
      3. • Market Estimates & Forecast, 2023-2032
    7. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. 6.2.2
      2. Right Ventricular Assist Devices
      3. • Market Estimates & Forecast, 2023-2032
    8. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. 6.2.3
      2. Bi-Ventricular Assist Devices
      3. • Market Estimates & Forecast, 2023-2032
    9. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. 6.2.4
      2. Percutaneous Ventricular Assist Devices
      3. • Market Estimates & Forecast,
    10. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. • Market Estimates &
      2. Forecast, 2023-2032
    11. Transcutaneous Ventricular Assist Devices
    12. • Market Estimates & Forecast, By Region/Country,
      1. Intra-Aortic Balloon Pumps
      2. • Market Estimates &
      3. Forecast, 2023-2032
    13. • Market Estimates & Forecast, By Region/Country,
      1. Total Artificial Heart
      2. • Market Estimates & Forecast,
    14. • Market Estimates & Forecast, By Region/Country, 2023-2032
    15. Global Heart Pump Devices Market, By Device Type
      1. Introduction
      2. 7.2
      3. Implantable Heart Pump Devices
      4. • Market Estimates & Forecast, 2023-2032
    16. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. 7.3
      2. Extracorporeal Heart Pump Devices
      3. • Market Estimates & Forecast, 2023-2032
    17. • Market Estimates & Forecast, By Region/Country, 2023-2032
    18. Global
    19. Heart Pump Devices Market, By Therapy
      1. Introduction
      2. Bridge-To-Candidacy
      3. • Market Estimates & Forecast, 2023-2032
      4. • Market Estimates
      5. & Forecast, By Region/Country, 2023-2032
      6. Bridge-To-Transplant
      7. •
      8. Market Estimates & Forecast, 2023-2032
      9. • Market Estimates & Forecast,
      10. By Region/Country, 2023-2032
      11. Destination Therapy
      12. • Market Estimates
      13. & Forecast, 2023-2032
    20. • Market Estimates & Forecast, By Region/Country,
      1. Others
      2. • Market Estimates & Forecast, 2023-2032
    21. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. •
    22. Global Heart Pump Devices Market, By End-User
      1. Introduction
      2. 9.2
      3. Hospitals & Clinics
      4. • Market Estimates & Forecast, 2023-2032
    23. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. 9.3
      2. Ambulatory Surgical Centers
      3. • Market Estimates & Forecast, 2023-2032
    24. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. 9.4
      2. Research Institutes
      3. • Market Estimates & Forecast, 2023-2032
      4. •
    25. Market Estimates & Forecast, By Region/Country, 2023-2032
      1. Others
      2. • Market Estimates & Forecast, 2023-2032
      3. • Market Estimates
      4. & Forecast, By Region/Country, 2023-2032
    26. Global Heart Pump Devices Market,
      1. By Region
      2. Introduction
      3. Americas
      4. • Market Estimates
      5. & Forecast, By Region, 2023-2032
      6. • Market Estimates & Forecast,
      7. By Product, 2023-2032
    27. • Market Estimates & Forecast, By Type, 2023-2032
    28. • Market Estimates & Forecast, By Therapy, 2023-2032
      1. • Market
      2. Estimates & Forecast, By End-User, 2023-2032
      3. •
    29. North America
    30. Market Estimates & Forecast, By Country, 2023-2032
      1. • Market Estimates
      2. & Forecast, By Product, 2023-2032
      3. • Market Estimates & Forecast,
      4. By Type, 2023-2032
    31. • Market Estimates & Forecast, By Therapy, 2023-2032
    32. • Market Estimates & Forecast, By End-User, 2023-2032
    33. U.S.
    34. • Market Estimates & Forecast, By Product, 2023-2032
      1. • Market
      2. Estimates & Forecast, By Type, 2023-2032
      3. • Market Estimates &
      4. Forecast, By Therapy, 2023-2032
      5. • Market Estimates & Forecast, By
      6. End-User, 2023-2032
      7. • Market Estimates & Forecast,
      8. By Product, 2023-2032
    35. Canada
    36. • Market Estimates & Forecast, By Type, 2023-2032
    37. • Market Estimates & Forecast, By Therapy, 2023-2032
      1. • Market
      2. Estimates & Forecast, By End-User, 2023-2032
      3. •
    38. South America
    39. Market Estimates & Forecast, By Product, 2023-2032
      1. • Market Estimates
      2. & Forecast, By Type, 2023-2032
      3. • Market Estimates & Forecast,
      4. By Therapy, 2023-2032
    40. • Market Estimates & Forecast, By End-User,
      1. Europe
    41. • Market Estimates & Forecast, By Region,
    42. • Market Estimates & Forecast, By Product, 2023-2032
    43. • Market Estimates & Forecast, By Type, 2023-2032
      1. • Market
      2. Estimates & Forecast, By Therapy, 2023-2032
      3. • Market Estimates &
      4. Forecast, By End-User, 2023-2032
      5. • Market Estimates
      6. & Forecast, By Country, 2023-2032
      7. • Market Estimates & Forecast,
      8. By Product, 2023-2032
    44. Western Europe
    45. • Market Estimates & Forecast, By Type, 2023-2032
    46. • Market Estimates & Forecast, By Therapy, 2023-2032
      1. • Market
      2. Estimates & Forecast, By End-User, 2023-2032
      3. •
    47. Germany
    48. Market Estimates & Forecast, By Product, 2023-2032
      1. • Market Estimates
      2. & Forecast, By Type, 2023-2032
      3. • Market Estimates & Forecast,
      4. By Therapy, 2023-2032
    49. • Market Estimates & Forecast, By End-User,
    50. France
    51. • Market Estimates & Forecast, By Product,
    52. • Market Estimates & Forecast, By Type, 2023-2032
      1. •
    53. Market Estimates & Forecast, By Therapy, 2023-2032
      1. • Market Estimates
      2. & Forecast, By End-User, 2023-2032
      3. • Market Estimates
      4. & Forecast, By Product, 2023-2032
      5. • Market Estimates & Forecast,
      6. By Type, 2023-2032
    54. U.K.
    55. • Market Estimates & Forecast, By Therapy, 2023-2032
    56. • Market Estimates & Forecast, By End-User, 2023-2032
    57. Italy
    58. • Market Estimates & Forecast, By Product, 2023-2032
      1. • Market
      2. Estimates & Forecast, By Type, 2023-2032
      3. • Market Estimates &
      4. Forecast, By Therapy, 2023-2032
      5. • Market Estimates & Forecast, By
      6. End-User, 2023-2032
      7. • Market Estimates & Forecast,
      8. By Product, 2023-2032
    59. Spain
    60. • Market Estimates & Forecast, By Type, 2023-2032
    61. • Market Estimates & Forecast, By Therapy, 2023-2032
      1. • Market
      2. Estimates & Forecast, By End-User, 2023-2032
    62. Rest Of Western Europe
    63. • Market Estimates & Forecast, By Product, 2023-2032
      1. • Market
      2. Estimates & Forecast, By Type, 2023-2032
      3. • Market Estimates &
      4. Forecast, By Therapy, 2023-2032
      5. • Market Estimates & Forecast, By
      6. End-User, 2023-2032
      7. • Market Estimates &
      8. Forecast, By Product, 2023-2032
      9. • Market Estimates & Forecast, By
      10. Type, 2023-2032
    64. Eastern Europe
    65. • Market Estimates & Forecast, By Therapy, 2023-2032
    66. • Market Estimates & Forecast, By End-User, 2023-2032
      1. Asia
      2. Pacific
    67. • Market Estimates & Forecast, By Country, 2023-2032
      1. •
    68. Market Estimates & Forecast, By Product, 2023-2032
      1. • Market Estimates
      2. & Forecast, By Type, 2023-2032
      3. • Market Estimates & Forecast,
      4. By Therapy, 2023-2032
    69. • Market Estimates & Forecast, By End-User,
    70. Japan
    71. • Market Estimates & Forecast, By Product,
    72. • Market Estimates & Forecast, By Type, 2023-2032
      1. •
    73. Market Estimates & Forecast, By Therapy, 2023-2032
      1. • Market Estimates
      2. & Forecast, By End-User, 2023-2032
      3. • Market Estimates
      4. & Forecast, By Product, 2023-2032
      5. • Market Estimates & Forecast,
      6. By Type, 2023-2032
    74. China
    75. • Market Estimates & Forecast, By Therapy, 2023-2032
    76. • Market Estimates & Forecast, By End-User, 2023-2032
    77. India
    78. • Market Estimates & Forecast, By Product, 2023-2032
      1. • Market
      2. Estimates & Forecast, By Type, 2023-2032
      3. • Market Estimates &
      4. Forecast, By Therapy, 2023-2032
      5. • Market Estimates & Forecast, By
      6. End-User, 2023-2032
      7. • Market Estimates & Forecast,
      8. By Product, 2023-2032
    79. Australia
    80. • Market Estimates & Forecast, By Type, 2023-2032
    81. • Market Estimates & Forecast, By Therapy, 2023-2032
      1. • Market
      2. Estimates & Forecast, By End-User, 2023-2032
    82. Republic Of Korea
    83. • Market Estimates & Forecast, By Product, 2023-2032
      1. • Market
      2. Estimates & Forecast, By Type, 2023-2032
      3. • Market Estimates &
      4. Forecast, By Therapy, 2023-2032
      5. • Market Estimates & Forecast, By
      6. End-User, 2023-2032
      7. • Market Estimates
      8. & Forecast, By Product, 2023-2032
      9. • Market Estimates & Forecast,
      10. By Type, 2023-2032
    84. Rest Of Asia Pacific
    85. • Market Estimates & Forecast, By Therapy, 2023-2032
    86. • Market Estimates & Forecast, By End-User, 2023-2032
      1. The Middle
      2. East & Africa
    87. • Market Estimates & Forecast, By Region, 2023-2032
    88. • Market Estimates & Forecast, By Product, 2023-2032
      1. • Market
      2. Estimates & Forecast, By Type, 2023-2032
      3. • Market Estimates &
      4. Forecast, By Therapy, 2023-2032
      5. • Market Estimates & Forecast, By
      6. End-User, 2023-2032
      7. • Market Estimates
      8. & Forecast, By Product, 2023-2032
      9. • Market Estimates & Forecast,
      10. By Type, 2023-2032
    89. United Arab Emirates
    90. • Market Estimates & Forecast, By Therapy, 2023-2032
    91. • Market Estimates & Forecast, By End-User, 2023-2032
      1. Arabia
    92. Saudi
    93. • Market Estimates & Forecast, By Product, 2023-2032
      1. •
    94. Market Estimates & Forecast, By Type, 2023-2032
      1. • Market Estimates
      2. & Forecast, By Therapy, 2023-2032
      3. • Market Estimates & Forecast,
      4. By End-User, 2023-2032
      5. • Market Estimates & Forecast,
      6. By Product, 2023-2032
    95. Oman
    96. • Market Estimates & Forecast, By Type, 2023-2032
    97. • Market Estimates & Forecast, By Therapy, 2023-2032
      1. • Market
      2. Estimates & Forecast, By End-User, 2023-2032
      3. •
    98. Kuwait
    99. Market Estimates & Forecast, By Product, 2023-2032
      1. • Market Estimates
      2. & Forecast, By Type, 2023-2032
      3. • Market Estimates & Forecast,
      4. By Therapy, 2023-2032
    100. • Market Estimates & Forecast, By End-User,
    101. Qatar
    102. • Market Estimates & Forecast, By Product,
    103. • Market Estimates & Forecast, By Type, 2023-2032
      1. •
    104. Market Estimates & Forecast, By Therapy, 2023-2032
      1. • Market Estimates
      2. & Forecast, By End-User, 2023-2032
      3. Africa
    105. Rest Of The Middle East &
    106. • Market Estimates & Forecast, By Product, 2023-2032
      1. •
    107. Market Estimates & Forecast, By Type, 2023-2032
      1. • Market Estimates
      2. & Forecast, By Therapy, 2023-2032
      3. • Market Estimates & Forecast,
      4. By End-User, 2023-2032
    108. Company Landscape
      1. Introduction
      2. 11.2
      3. Market Share Analysis
      4. Key Development & Strategies
        1. Key
      5. Developments
    109. Company Profiles
      1. Abbott Laboratories
        1. Product Overview
        2. Financials
      2. 12.1.1
      3. Company Overview
      4. 12.1.4
      5. SWOT Analysis
      6. Abiomed
        1. Company Overview
        2. Product
        3. Financial Overview
        4. Key Developments
      7. Overview
      8. 12.2.5
      9. SWOT Analysis
      10. Medtronic
        1. Company Overview
        2. Product
        3. Financial Overview
        4. Key Development
      11. Overview
      12. 12.3.5
      13. SWOT Analysis
      14. Getinge
        1. Company Overview
        2. Product/Business
        3. Financial Overview
        4. Key Development
      15. Segment Overview
      16. 12.4.5
      17. SWOT Analysis
      18. Syncardia Systems
        1. Company Overview
        2. Financial Overview
        3. Key Developments
      19. 12.5.2
      20. Product Overview
      21. Teleflex
        1. Company Overview
        2. Product Overview
        3. Key Developments
      22. 12.6.3
      23. Financial Overview
      24. Reliantheart
        1. Product Overview
        2. Financials
        3. Key Developments
        4. SWOT Analysis
      25. 12.7.1
      26. Overview
      27. Terumo
        1. Overview
        2. Product
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      28. Overview
      29. Berlin Heart
        1. Overview
        2. Product Overview
        3. Key Developments
        4. SWOT Analysis
      30. 12.9.3
      31. Financials
      32. Jarvik
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      33. Heart
      34. Cardiacassist
        1. Overview
        2. Product Overview
        3. Financials
        4. SWOT Analysis
      35. 12.11.4
      36. Key Developments
      37. Fresenius Medical Care
        1. Overview
        2. Product Overview
        3. Financials
        4. SWOT Analysis
      38. 12.12.4
      39. Key Developments
      40. Thoratec Corporation
        1. Product Overview
        2. Financials
        3. Key
        4. SWOT Analysis
      41. 12.13.1
      42. Overview
      43. Developments
      44. HeartWare
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      45. MAQUET GmbH & Co
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
    110. Appendix
    111. LIST OF TABLES
    112. Heart
      1. Pump Devices Industry Synopsis, 2023-2032
    113. Global Heart Pump Devices
      1. Market Estimates And Forecast, 2023-2032, (USD Million)
    114. Global Heart
    115. Pump Devices Market, By Region, 2023-2032, (USD Million)
    116. Global Heart
    117. Pump Devices Market, By Type, 2023-2032, (USD Million)
    118. Global Heart
    119. Pump Devices Market, By Product, 2023-2032, (USD Million)
    120. Global Heart
    121. Pump Devices Market, By Therapy, 2023-2032, (USD Million)
    122. Global Heart
    123. Pump Devices Market, By End-Users, 2023-2032, (USD Million)
    124. North America
    125. Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
    126. North
    127. America Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
      1. Table
    128. North America Heart Pump Devices Market, By Product, 2023-2032, (USD Million)
    129. North America Heart Pump Devices Market, By End-Users, 2023-2032, (USD
      1. Million)
    130. U.S. Heart Pump Devices Market, By Type, 2023-2032, (USD
      1. Million)
    131. U.S. Heart Pump Devices Market, By Therapy, 2023-2032, (USD
      1. Million)
    132. U.S. Heart Pump Devices Market, By Product, 2023-2032, (USD
      1. Million)
    133. U.S. Heart Pump Devices Market, By End-Users, 2023-2032,
      1. (USD Million)
    134. Canada Heart Pump Devices Market, By Type, 2023-2032,
      1. (USD Million)
    135. Canada Heart Pump Devices Market, By Product, 2023-2032,
      1. (USD Million)
    136. Canada Heart Pump Devices Market, By Therapy, 2023-2032,
      1. (USD Million)
    137. Canada Heart Pump Devices Market, By End-Users, 2023-2032,
      1. (USD Million)
    138. South America Heart Pump Devices Market, By Type, 2023-2032,
      1. (USD Million)
    139. South America Heart Pump Devices Market, By Therapy,
    140. South America Heart Pump Devices Market,
      1. By End-Users, 2023-2032, (USD Million)
    141. Europe Heart Pump Devices Market,
      1. By Type, 2023-2032, (USD Million)
    142. Europe Heart Pump Devices Market,
      1. By Therapy, 2023-2032, (USD Million)
    143. Europe Heart Pump Devices Market,
      1. By End-Users, 2023-2032, (USD Million)
    144. Western Europe Heart Pump Devices
    145. Market, By Type, 2023-2032, (USD Million)
    146. Western Europe Heart Pump
    147. Devices Market, By Therapy, 2023-2032, (USD Million)
    148. Western Europe
    149. Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
      1. Table 26
    150. Eastern Europe Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
      1. Table
    151. Eastern Europe Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
    152. Eastern Europe Heart Pump Devices Market, By End-Users, 2023-2032, (USD
      1. Million)
    153. Asia Pacific Heart Pump Devices Market, By Type, 2023-2032,
      1. (USD Million)
    154. Asia Pacific Heart Pump Devices Market, By Therapy,
    155. Asia Pacific Heart Pump Devices Market, By
      1. End-Users, 2023-2032, (USD Million)
    156. Middle East & Africa Heart
    157. Pump Devices Market, By Type, 2023-2032, (USD Million)
    158. Middle East
    159. & Africa Heart Pump Devices Market, By Diagnoses, 2023-2032, (USD Million)
    160. Middle East & Africa Heart Pump Devices Market, By End-Users, 2023-2032,
      1. (USD Million)
      2.  
    161. LIST OF FIGURES
    162. Research Process
    163. Segmentation For Global Heart Pump Devices Market
    164. Segmentation
      1. Market Dynamics For Heart Pump Devices Market
    165. Global Heart Pump Devices
    166. Market Share, By Type 2020
    167. Global Heart Pump Devices Market Share,
      1. By Product 2020
    168. Global Heart Pump Devices Market Share, By End-Users,
    169. Global Heart Pump Devices Market Share, By Region, 2020
      1. Figure
    170. North America Heart Pump Devices Market Share, By Country, 2020
      1. Figure 9
    171. Europe Heart Pump Devices Market Share, By Country, 2020
    172. Asia Pacific
    173. Heart Pump Devices Market Share, By Country, 2020
    174. Middle East &
    175. Africa Heart Pump Devices Market Share, By Country, 2020
    176. Global Heart
      1. Pump Devices Market: Company Share Analysis, 2020 (%)
    177. Abbott Laboratories:
      1. Key Financials
    178. Abbott Laboratories: Segmental Revenue
      1. Figure
    179. Abbott Laboratories: Geographical Revenue
    180. Medtronic. Key Financials
    181. Medtronic: Segmental Revenue
    182. Medtronic: Geographical
      1. Revenue
    183. Terumo: Key Financials
    184. Terumo: Segmental Revenue
    185. Terumo: Geographical Revenue
    186. Getinge: Key Financials
    187. Getinge: Segmental Revenue
    188. Getinge: Geographical Revenue
    189. Teleflex: Key Financials
    190. Teleflex: Segmental Revenue
    191. Teleflex. Geographical Revenue
    192. Abiomed. Key Financials
    193. Abiomed. Segmental Revenue
    194. Abiomed. Geographical Revenue
    195. Cardiacassist. Key Financials
    196. Cardiacassist. Segmental
      1. Revenue
    197. Cardiacassist. Geographical Revenue

    Heart Pump Devices Market Segmentation

    Heart Pump Devices Product Outlook (USD Billion, 2018-2032)

    • Ventricular assist devices
    • Left ventricular assist devices
    • Right ventricular assist devices
    • Bi- ventricular assist devices
    • Percutaneous ventricular assist devices
    • Transcutaneous ventricular assist devices
    • Intra-Aortic balloon pumps
    • Total artificial heart

    Heart Pump Devices, Device type Outlook (USD Billion, 2018-2032)

    • Implantable heart pump devices
    • Extracorporeal heart pump devices

    Heart Pump Devices Therapy Outlook (USD Billion, 2018-2032)

    • Bridge-to-candidacy (BTC)
    • Bridge-to-transplant (BTC)
    • Destination therapy (DT)
    • Others

    Heart Pump Devices End-user Outlook (USD Billion, 2018-2032)

    • Hospitals & Clinics
    • Ambulatory surgical centers
    • Research institutes
    • Others

    Heart Pump Devices Regional Outlook (USD Billion, 2018-2032)

    • North America Outlook (USD Billion, 2018-2032)

      • North America Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • North America Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • North America Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • North America Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • US Outlook (USD Billion, 2018-2032)

      • US Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • US Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • US Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • US Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • CANADA Outlook (USD Billion, 2018-2032)

      • CANADA Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • CANADA Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • CANADA Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • CANADA Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

    • Europe Outlook (USD Billion, 2018-2032)

      • Europe Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Europe Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Europe Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • Europe Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Germany Outlook (USD Billion, 2018-2032)

      • Germany Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Germany Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Germany Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • Germany Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • France Outlook (USD Billion, 2018-2032)

      • France Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • France Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • France Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • France Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • UK Outlook (USD Billion, 2018-2032)

      • UK Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • UK Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • UK Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • UK Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • ITALY Outlook (USD Billion, 2018-2032)

      • ITALY Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • ITALY Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • ITALY Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination therapy (DT)
        • Others
      • ITALY Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • SPAIN Outlook (USD Billion, 2018-2032)

      • Spain Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Spain Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Spain Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Spain Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Rest Of Europe Outlook (USD Billion, 2018-2032)

      • Rest Of Europe Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • REST OF EUROPE Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • REST OF EUROPE Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • REST OF EUROPE Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

    • Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Asia-Pacific Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Asia-Pacific Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Asia-Pacific Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Asia-Pacific Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • China Outlook (USD Billion, 2018-2032)

      • China Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • China Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • China Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • China Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Japan Outlook (USD Billion, 2018-2032)

      • Japan Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Japan Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Japan Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Japan Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • India Outlook (USD Billion, 2018-2032)

      • India Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • India Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • India Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • India Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Australia Outlook (USD Billion, 2018-2032)

      • Australia Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Australia Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Australia Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Australia Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Rest of Asia-Pacific Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Rest of Asia-Pacific Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Rest of Asia-Pacific Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Rest of Asia-Pacific Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

    • Rest of the World Outlook (USD Billion, 2018-2032)

      • Rest of the World Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Rest of the World Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Rest of the World Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Rest of the World Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Middle East Outlook (USD Billion, 2018-2032)

      • Middle East Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Middle East Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Middle East Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Middle East Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Africa Outlook (USD Billion, 2018-2032)

      • Africa Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Africa Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Africa Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Africa Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others

      • Latin America Outlook (USD Billion, 2018-2032)

      • Latin America Heart Pump Devices by Product
        • Ventricular assist devices
        • Left ventricular assist devices
        • Right ventricular assist devices
        • Bi- ventricular assist devices
        • Percutaneous ventricular assist devices
        • Transcutaneous ventricular assist devices
        • Intra-Aortic balloon pumps
        • Total artificial heart
      • Latin America Heart Pump Devices by Device type
        • Implantable heart pump devices
        • Extracorporeal heart pump devices
      • Latin America Heart Pump Devices by Therapy
        • Bridge-to-candidacy (BTC)
        • Bridge-to-transplant (BTC)
        • Destination Therapy (DT)
        • Others
      • Latin America Heart Pump Devices by End-user
        • Hospitals & Clinics
        • Ambulatory surgical centers
        • Research institutes
        • Others
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027